Aquinox Pharmaceuticals Inc. (NASDAQ:AQXP) was up 2.7% during mid-day trading on Friday . The stock traded as high as $7.55 and last traded at $7.50, with a volume of 66,464 shares traded. The stock had previously closed at $7.30.

Separately, Needham & Company LLC started coverage on Aquinox Pharmaceuticals in a report on Thursday, May 12th. They issued a “buy” rating and a $25.00 price target for the company. One equities research analyst has rated the stock with a sell rating, one has assigned a hold rating and five have issued a buy rating to the stock. Aquinox Pharmaceuticals has an average rating of “Buy” and an average target price of $19.86.

The stock’s market capitalization is $128.39 million. The firm has a 50-day moving average of $7.21 and a 200-day moving average of $8.77.

Aquinox Pharmaceuticals (NASDAQ:AQXP) last released its quarterly earnings data on Tuesday, May 10th. The company reported ($0.39) earnings per share for the quarter, missing the Thomson Reuters’ consensus estimate of ($0.35) by $0.04. Equities analysts anticipate that Aquinox Pharmaceuticals Inc. will post ($1.79) EPS for the current fiscal year.

Aquinox Pharmaceuticals, Inc, formerly Aquinox Pharmaceuticals (USA) Inc, is a clinical stage pharmaceutical company discovering and developing targeted therapeutics in disease areas of inflammation and immuno-oncology. Aquinox Pharmaceuticals (Canada) Inc is a wholly owned subsidiary of the Company.

Get Analysts' Upgrades and Downgrades Daily - Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with's FREE daily email newsletter.